U.S. flag

An official website of the United States government

GTR Home > Tests > CancerNext® 37

Overview

Test order codeHelp: 8825

Test name

Help

CancerNext® 37

Purpose of the test

Help

This is a clinical test intended for Help: Pre-symptomatic, Diagnosis

Condition

Help

Loading data ......

Click Indication tab for more information.

How to order

Help

Order URL Help: http://www.ambrygen.com/clinician/ordering-process

Specimen source

Fibroblasts
Saliva
Semen
Fetal blood
Bone marrow
Buffy coat
Cell culture
Dried blood spot (DBS) card
Product of conception (POC)
Peripheral (whole) blood
Isolated DNA

Methodology

Help
Molecular Genetics
DDeletion/duplication analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
CSequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)

Summary of what is tested

Loading data ......

Click Methodology tab for more information.

Clinical utility

Help

Not provided

Clinical validity

Help

Clinical validity depends on specific clinical and family history.

Citations

Not provided

Test services

Help
  • Clinical Testing/Confirmation of Mutations Identified Previously, Order code: 5555

Practice guidelines

  • NICE, 2019
    UK NICE Clinical Guideline CG164, Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer, 2019
  • ACMG ACT, 2019
    American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, BRCA1 and BRCA2 Pathogenic Variants (Hereditary Breast and Ovarian Cancer), 2019

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.